EUVIMEDEUVIMED entdecken
Crossref

A DNAzyme-Driven DNA Nanotracker for Orthogonal Dual-Channel Imaging of an Oncogenic Signaling Axis and Its Pharmacological Modulation

Qianying Zhang iD, Jingyi Zheng, Kaiyue Liu, Jian-Rong Zhang, Sai Bi iD, Jun-Jie Zhu iD

Nano Letters · 2026

DOI: 10.1021/acs.nanolett.6c02711 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nano Letters, 2026. Verfasst von Qianying Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry and Chemical Engineering, Qingdao Key Laboratory of Intelligent Molecular Manufacturing and Precise Health, Shandong Provincial …. Hauptthemen laut MEDLINE: DNA, Catalytic, Metal Nanoparticles, MicroRNAs, Carcinoma, Hepatocellular. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province, Taishan Scholar Foundation of Shandong Province, Natural Science Foundation of Qingdao Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pathway-targeted therapy has emerged as a promising strategy in cancer treatment, yet its efficacy relies on the accurate analysis of key signaling axes in living cells. The miR-140/FEN1 signaling axis, which is balanced in normal hepatocytes but dysregulated in hepatocellular carcinoma, represents a potential target for cancer therapy. Here, we present a DNAzyme-driven DNA nanotracker (DDN) for the orthogonal imaging of this pathway in dual channels with high sensitivity. The nanotracker is constructed by assembling DNAzyme-powered DNA walkers, which are responsive to miR-140 and FEN1, onto gold nanoparticles, enabling simultaneous visualization of upstream miRNA expression and downstream enzymatic activity in living cells. Leveraging this platform, we further revealed the differential pharmacological modulations of the miR-140/FEN1 signaling axis by simvastatin and myricetin. In summary, the DDN serves not only as a sensitive molecular imaging probe but also as a versatile tool for mechanistic studies, offering advanced opportunities for pathway-guided drug discovery and precision therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA, CatalyticMetal NanoparticlesMicroRNAsCarcinoma, HepatocellularLiver NeoplasmsHumansGoldSignal TransductionDNA NanostructuresFlavonoidsMolecular ImagingDNACell Line, Tumor

Stichwörter der Autor:innen

DNA nanotrackerDNAzyme walkerorthogonal dual-channel imagingsignaling axis visualization

Substanzen

DNA, CatalyticGoldMicroRNAsmyricetinFlavonoidsDNA

Autor:innen und Institutionen

  • College of Chemistry and Chemical Engineering, Qingdao Key Laboratory of Intelligent Molecular Manufacturing and Precise Health, Shandong Provincial Key Laboratory of Intelligent Molecular Science and Engineering, Qingd…
  • State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing210023, China.

ORCID-Profile: Qianying Zhang, Sai Bi, Jun-Jie Zhu

Förderung

  • Natural Science Foundation of Shandong Province
  • Taishan Scholar Foundation of Shandong Province
  • Natural Science Foundation of Qingdao Municipality
  • National Key R&D Program of China-?Intergovernmental International Cooperation on Science and Technology Innovation? Key Special Project
  • Open Project of Shandong Provincial Key Laboratory for Tumor Imaging Equipment Development and Tumor Diagnosis & Treatment Integration Technology
  • National Natural Science Foundation of China (NSFC)
  • Youth Innovation Science and Technology Plan of Shandong Province
  • National Key R&D Program of China-“Intergovernmental International Cooperation on Science and Technology Innovation” Key Special Project

Zitieren

APA

Zhang, Q., Zheng, J., Liu, K., Zhang, J. R., Bi, S., & Zhu, J. J. (2026). A DNAzyme-Driven DNA Nanotracker for Orthogonal Dual-Channel Imaging of an Oncogenic Signaling Axis and Its Pharmacological Modulation. Nano Letters. https://doi.org/10.1021/acs.nanolett.6c02711

Vancouver

Zhang Q, Zheng J, Liu K, Zhang JR, Bi S, Zhu JJ. A DNAzyme-Driven DNA Nanotracker for Orthogonal Dual-Channel Imaging of an Oncogenic Signaling Axis and Its Pharmacological Modulation. Nano Letters. 2026. doi:10.1021/acs.nanolett.6c02711

BibTeX
@article{Zhang2026,
  author = {Zhang, Qianying and Zheng, Jingyi and Liu, Kaiyue and Zhang, Jian-Rong and Bi, Sai and Zhu, Jun-Jie},
  title = {A DNAzyme-Driven DNA Nanotracker for Orthogonal Dual-Channel Imaging of an Oncogenic Signaling Axis and Its Pharmacological Modulation},
  journal = {Nano Letters},
  year = {2026},
  doi = {10.1021/acs.nanolett.6c02711}
}
Kostenlos starten →